XML 23 R13.htm IDEA: XBRL DOCUMENT

Intangibles

9 Months Ended

Sep. 30, 2018

Goodwill and Intangible Assets Disclosure [Abstract]

INTANGIBLES

The change in the carrying amount of goodwill by segment for the nine months ended September 30, 2018 is as follows:



In thousands	Freight Segment				Transit Segment				Total
Balance at December 31, 2017	$	718,958			$	1,741,145			$	2,460,103
Additions	5,252				13,707				18,959
Foreign currency impact	(7,710		)		(58,798		)		(66,508		)
Balance at September 30, 2018	$	716,500			$	1,696,054			$	2,412,554

As of September 30, 2018, and December 31, 2017, the Company’s trade names had a net carrying amount of $599.5 million and $603.4 million, respectively, and the Company believes these intangibles have indefinite lives.

Intangible assets of the Company, other than goodwill and trade names, consist of the following:



In thousands	September 30, 2018				December 31, 2017
Patents, non-compete and other intangibles, net of accumulated
amortization of $42,928 and $43,021	$	15,192			$	17,554
Customer relationships, net of accumulated amortization
of $151,007 and $126,824	542,780				583,459
Total	$	557,972			$	601,013

The weighted average remaining useful life of patents, customer relationships and other intangibles are 10 years, 16 years and 14 years, respectively. Amortization expense for intangible assets was $9.9 million and $30.1 million for the three and nine months ended September 30, 2018, and $8.6 million and $27.0 million for the three and nine months ended September 30, 2017, respectively.

Amortization expense for the five succeeding years is estimated to be as follows:



Remainder of 2018	$	10,460
2019	38,335
2020	36,099
2021	35,608
2022	35,320

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References + Details